MX2017002749A - Metodo para la preparacion de imidazopiridazinas sustituidas. - Google Patents

Metodo para la preparacion de imidazopiridazinas sustituidas.

Info

Publication number
MX2017002749A
MX2017002749A MX2017002749A MX2017002749A MX2017002749A MX 2017002749 A MX2017002749 A MX 2017002749A MX 2017002749 A MX2017002749 A MX 2017002749A MX 2017002749 A MX2017002749 A MX 2017002749A MX 2017002749 A MX2017002749 A MX 2017002749A
Authority
MX
Mexico
Prior art keywords
imidazo
alkylamino
phenoxy
heteroaryl
phenyl
Prior art date
Application number
MX2017002749A
Other languages
English (en)
Inventor
Paulsen Holger
Muenster Uwe
GUIMOND Nicolas
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MX2017002749A publication Critical patent/MX2017002749A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B41/00—Formation or introduction of functional groups containing oxygen
    • C07B41/02—Formation or introduction of functional groups containing oxygen of hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Métodos para preparar compuestos imidazopiridazina sustituidos de fórmula general (I) como se describe y define en la presente, así como también compuestos intermediarios útiles para la preparación de dichos compuestos.
MX2017002749A 2014-09-01 2015-08-28 Metodo para la preparacion de imidazopiridazinas sustituidas. MX2017002749A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14183029 2014-09-01
PCT/EP2015/069739 WO2016034507A1 (en) 2014-09-01 2015-08-28 A process for the preparation of 3-phenyl/heteroaryl-6-phenoxy-8-alkylamino-imidazo[1,2-b]pyridazine derivatives

Publications (1)

Publication Number Publication Date
MX2017002749A true MX2017002749A (es) 2017-07-26

Family

ID=51422014

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002749A MX2017002749A (es) 2014-09-01 2015-08-28 Metodo para la preparacion de imidazopiridazinas sustituidas.

Country Status (19)

Country Link
US (1) US20170305912A1 (es)
EP (1) EP3189055A1 (es)
JP (1) JP2017525725A (es)
KR (1) KR20170044166A (es)
CN (1) CN106795164A (es)
AR (1) AR101730A1 (es)
AU (1) AU2015311011A1 (es)
BR (1) BR112017003916A2 (es)
CA (1) CA2959224A1 (es)
CO (1) CO2017002070A2 (es)
IL (1) IL250264A0 (es)
MX (1) MX2017002749A (es)
PE (1) PE20170447A1 (es)
RU (1) RU2017110880A (es)
SG (1) SG11201700818XA (es)
TW (1) TW201613927A (es)
UY (1) UY36284A (es)
WO (1) WO2016034507A1 (es)
ZA (1) ZA201702297B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078136A1 (en) 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
TW201107329A (en) * 2009-07-30 2011-03-01 Oncotherapy Science Inc Fused imidazole derivative having ttk inhibitory action
TWI541243B (zh) 2010-09-10 2016-07-11 拜耳知識產權公司 經取代咪唑并嗒
WO2014020041A1 (en) * 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
CA2890861C (en) 2012-11-21 2021-03-30 Raqualia Pharma Inc. Polymorphic forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid
TW201437211A (zh) * 2013-03-01 2014-10-01 Bayer Pharma AG 經取代咪唑并嗒□
MA38657A1 (fr) * 2013-06-13 2018-05-31 Bayer Pharma AG Combinaison d'un dérivé d'imidazopyridazine et d'un agent mitotique pour le traitement du cancer

Also Published As

Publication number Publication date
WO2016034507A1 (en) 2016-03-10
TW201613927A (en) 2016-04-16
CO2017002070A2 (es) 2017-05-19
PE20170447A1 (es) 2017-05-18
JP2017525725A (ja) 2017-09-07
RU2017110880A (ru) 2018-10-03
CA2959224A1 (en) 2016-03-10
CN106795164A (zh) 2017-05-31
EP3189055A1 (en) 2017-07-12
AU2015311011A1 (en) 2017-02-23
BR112017003916A2 (pt) 2018-03-06
US20170305912A1 (en) 2017-10-26
KR20170044166A (ko) 2017-04-24
IL250264A0 (en) 2017-03-30
UY36284A (es) 2016-04-01
ZA201702297B (en) 2018-12-19
SG11201700818XA (en) 2017-03-30
AR101730A1 (es) 2017-01-11

Similar Documents

Publication Publication Date Title
IL277576A (en) Mutated pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
IL265918B (en) Converted pyrazolo[1,5–a]pyridine compounds as ret kinase inhibitors
EP3268000A4 (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
SI3322706T1 (sl) Substituirane pirazolo(1,5-A)piridinske spojine kot zaviralci ret-kinaze
SI3419978T1 (sl) Derivati pirazolo(1,5-A)pirazin-4-ila kot zaviralci z janusom povezane kinaze (JAK)
IL286912A (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
IL254224A0 (en) 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors
NZ739876A (en) Process for preparing parp inhibitor, crystalline forms, and uses thereof
IL266305B (en) History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors
MX2017016772A (es) Metodo para producir un derivado de 7h-pirrolo[2,3-d]pirimidina e intermediario del mismo.
MX368162B (es) Derivados de pirazolo[1,5-a]pirimidina sustituida con piperidina con actividad inhibidora sobre la replicacion del virus sincicial respiratorio (vsr).
PH12017501123A1 (en) Solid state forms of fused heteroaromatic pyrrolidinones
MX2017013874A (es) Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa.
CL2015003068A1 (es) Formulaciones farmacéuticas, procesos, formas sólidas y métodos para el uso relacionado con 1-etil-7-(2-metil-6-(1h-1,2,4-triazol-3-il)piridin-3-il)-3,4-dihidropirazino[2,3-b]pirazin-2(1h)-ona
IL290419B (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
WO2018218197A3 (en) ATR KINASE INHIBITORS BASED ON TETRAHYDROPYRIDO [4,3-D] PYRIMIDINE
AU2015295120A8 (en) [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases
MX368323B (es) Derivados tricíclicos de pirazolo [1,5-a]pirimidina sustituidos con piperidina con actividad inhibidora en la replicación del virus sincitial respiratorio (vsr).
PH12019500478A1 (en) 8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereof
NZ714742A (en) Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
MX2017002749A (es) Metodo para la preparacion de imidazopiridazinas sustituidas.
MX2021002794A (es) Metodo mejorado para la fabricacion de 3-[(1s)-1-imidazo[1,2-a]pir idin-6- iletil]-5-(1-metilpirazol-4-il)triazolo[4,5-b]pirazina y formas polimorficas de la misma.